香港股市 已收市

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
7.88-0.01 (-0.13%)
收市:04:00PM EDT
7.51 -0.37 (-4.70%)
收市後: 06:34PM EDT

Treace Medical Concepts, Inc.

100 Palmetto Park Place
Ponte Vedra, FL 32081
United States
904 373 5940
https://www.treace.com

版塊Healthcare
行業Medical Devices
全職員工516

高階主管

名稱頭銜支付行使價出生年份
Mr. John T. TreaceCEO, Founder & Director1.09M1972
Mr. Mark L. Hair CPAChief Financial Officer599.7k1970
Mr. Aaron J. BeruttiSenior Vice President of Sales484.22k1979
Mr. Terry W. LubbenSenior Vice President of Operations1965
Mr. Taylor EricksonChief Information Officer
Mr. Scot M. Elder J.D.Chief Legal & Compliance Officer and Corporate Secretary1975
Mr. Nathan MinnichSenior Vice President of Marketing
Mr. Daniel E. OwensChief Human Resources Officer1972
Dr. Sean F. Scanlan Ph.D.Chief Innovation Officer1982
Ms. Shana ZinkSenior Vice President of Clinical Affairs, Medical Education & Reimbursement
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

公司管治

截至 2024年7月1日 止,Treace Medical Concepts, Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中:5;董事會:9;股東權利:8;現金賠償:6。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。